Resultados de búsqueda - Norbert Frickhofen

Limitar resultados
  1. 1
    Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia

    Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia por Norbert Frickhofen, H. Heimpel, J. P. Kaltwasser, Hubert Schrezenmeier

    Publicado 2003
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  2. 2
    First continuous propagation of B19 parvovirus in a cell line

    First continuous propagation of B19 parvovirus in a cell line por Shuichi Shimomura, Norio Komatsu, Norbert Frickhofen, Sarah N. Anderson, Sachiko Kajigaya, NS Young

    Publicado 1992
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  3. 3
    Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia

    Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia por W. Digel, Martin Štefanič, W Schöniger, C. Buck, A. Raghavachar, Norbert Frickhofen, H. Heimpel, Franz Porzsolt

    Publicado 1989
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  4. 4
    Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients

    Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients por Christian Walter, Bilal Al‐Nawas, Norbert Frickhofen, H. Gamm, Joachim Beck, Laura Reinsch, Christina Blum, Knut A. Grötz, Wilfried Wagner

    Publicado 2010
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  5. 5
    Whole-body 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin’s disease

    Whole-body 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin’s disease por Markus Bangerter, Florian Moog, Inga Buchmann, J. Kotzerke, Martin Grießhammer, Matthias Häfner, Klaus Elsner, Norbert Frickhofen, S. N. Reske, Lothar Bergmann

    Publicado 1998
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  6. 6
    Hepatitis C virus infection is a risk factor for liver failure from veno-occlusive disease after bone marrow transplantation [see comments]

    Hepatitis C virus infection is a risk factor for liver failure from veno-occlusive disease after bone marrow transplantation [see comments] por Norbert Frickhofen, Markus Wiesneth, C. Jainta, Bernd Hertenstein, B Heymer, Leonardo Bianchi, HP Dienes, K. Koerner, Donald Bunjes, R. Arnold

    Publicado 1994
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  7. 7
    High-Dose Chemotherapy With Autologous Stem-Cell Transplantation and Hyperfractionated Radiotherapy As First-Line Treatment of Primary CNS Lymphoma

    High-Dose Chemotherapy With Autologous Stem-Cell Transplantation and Hyperfractionated Radiotherapy As First-Line Treatment of Primary CNS Lymphoma por Gerald Illerhaus, Reinhard Marks, Gabriele Ihorst, Roland Guttenberger, Christoph B. Ostertag, Günther Derigs, Norbert Frickhofen, Friedrich Feuerhake, Benedikt Volk, Jürgen Finke

    Publicado 2006
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  8. 8
    Treatment of Aplastic Anemia with Antilymphocyte Globulin and Methylprednisolone with or without Cyclosporine

    Treatment of Aplastic Anemia with Antilymphocyte Globulin and Methylprednisolone with or without Cyclosporine por Norbert Frickhofen, J. P. Kaltwasser, Hubert Schrezenmeier, Aruna Raghavachar, Hans‐Georg Vogt, F. Herrmann, M. Freund, P. Meusers, A Salama, H. Heimpel

    Publicado 1991
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  9. 9
    The Efficacy and Safety of BI 2536, a Novel Plk-1 Inhibitor, in Patients with Stage IIIB/IV Non-small Cell Lung Cancer Who Had Relapsed after, or Failed, Chemotherapy: Results from an Open-Label, Randomized Phase II Clinical Trial

    The Efficacy and Safety of BI 2536, a Novel Plk-1 Inhibitor, in Patients with Stage IIIB/IV Non-small Cell Lung Cancer Who Had Relapsed after, or Failed, Chemotherapy: Results from... por Martin Sebastian, Martin Reck, Cornelius F. Waller, C. Kortsik, Norbert Frickhofen, Martin Schüler, Holger Fritsch, Birgit Gaschler‐Markefski, Gertraud Hanft, Gerd Munzert, Joachim von Pawel

    Publicado 2010
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  10. 10
    Malignant Tumors Occurring after Treatment of Aplastic Anemia

    Malignant Tumors Occurring after Treatment of Aplastic Anemia por Gèrard Socié, M. Henry‐Amar, Andrea Bacigalupo, Jill Hows, André Tichelli, Per Ljungman, Shaun R. McCann, Norbert Frickhofen, Elizabeth Van't Veer-Korthof, Éliane Gluckman

    Publicado 1993
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  11. 11
    Optimization of rituximab for the treatment of <scp>DLBCL</scp>: increasing the dose for elderly male patients

    Optimization of rituximab for the treatment of <scp>DLBCL</scp>: increasing the dose for elderly male patients por Michael Pfreundschuh, Niels Murawski, Samira Zeynalova, Marita Ziepert, Markus Loeffler, Matthias Hänel, Judith Dierlamm, Ulrich Keller, Martin Dreyling, Lorenz Truemper, Norbert Frickhofen, Ali‐Nuri Hünerlitürkoglu, Norbert Schmitz, Viola Pöschel, Tanja Rixecker, Christian Berdel, Christian Rübe, Gerhard Held, Carsten Zwick

    Publicado 2017
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  12. 12
    Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study

    Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study por Michael Kreuter, Johan Vansteenkiste, J.R. Fischer, Wilfried Eberhardt, Heike Zabeck, Jens Kollmeier, Monika Serke, Norbert Frickhofen, Martin Reck, Walburga Engel-Riedel, Silke Neumann, Michiel Thomeer, Christian Schumann, Paul De Leyn, Thomas Graeter, Georgios Stamatis, I. Zuna, Frank Griesinger, Michael Thomas

    Publicado 2012
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  13. 13
    Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry

    Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry por Sebastian Birndt, Thomas Schenk, B. Heinevetter, Frank M. Brunkhorst, Georg Maschmeyer, Frank Rothmann, Thomas Weber, Markus Müller, Jens Panse, Olaf Penack, Roland Schroers, Jan Braess, Norbert Frickhofen, Stephan Ehl, Gritta Janka, Kai Lehmberg, Mathias W. Pletz, Andreas Hochhaus, Thomas Ernst, Paul La Rosée

    Publicado 2020
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  14. 14
    High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)

    High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study) por Kristina Fritsch, Benjamin Kasenda, Elisabeth Schorb, Peter Hau, Johannes Bloehdorn, Robert Möhle, Steffen Löw, Mascha Binder, J. Atta, Ulrich Keller, H-H Wolf, Stefan W. Krause, Georg Heß, Ralph Naumann, Stephanie Sasse, Carsten Hirt, Monika Lamprecht, Uwe M. Martens, Anke Morgner, Jens Panse, Norbert Frickhofen, Alexander Röth, Claudia Hader, Martina Deckert, Heidi Fricker, Gabriele Ihorst, Jürgen Finke, Gerald Illerhaus

    Publicado 2016
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  15. 15
    <i>EZH2</i> mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia

    <i>EZH2</i> mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia por Sebastian Stasik, Jan Moritz Middeke, Michael Krämer, Christoph Röllig, Alwin Krämer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H. Brümmendorf, Ralph Naumann, Björn Steffen, Volker Kunzmann, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer‐Eckart, Christoph Schliemann, Stefan W. Krause, Regina Herbst, Mathias Hänel, Norbert Frickhofen, Richard Noppeney, Ulrich Kaiser, Claudia D. Baldus, Martin Kaufmann, Zdeněk Ráčil, Uwe Platzbecker, Wolfgang E. Berdel, Jiřı́ Mayer, Hubert Serve, Carsten Müller‐Tidow, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig, Christian Thiede

    Publicado 2019
    Enlace del recurso Enlace del recurso
    Carta
    Agregar a favoritos
    Guardado en:
  16. 16
    Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

    Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a rando... por Viola Poeschel, Gerhard Held, Marita Ziepert, Mathias Witzens‐Harig, Harald Holte, Lorenz Thurner, Peter Borchmann, Andreas Viardot, Martin Soekler, Ulrich Keller, Christian Schmidt, Lorenz Truemper, Rolf Mahlberg, Reinhard Marks, Heinz‐Gert Hoeffkes, Bernd Metzner, Judith Dierlamm, Norbert Frickhofen, Mathias Haenel, Andreas Neubauer, Michael Kneba, Francesco Merli, Alessandra Tucci, Peter de Nully Brown, Massimo Federico, Eva Lengfelder, Alice Di Rocco, Ralf Ulrich Trappe, Andreas Rosenwald, Christian Berdel, Martin Maisenhoelder, Ofer Shpilberg, Josif Amam, Konstantinos Christofyllakis, Frank Hartmann, Niels Murawski, Stephan Stilgenbauer, Maike Nickelsen, Gerald Wulf, Bertram Glaß, Norbert Schmitz, Bettina Altmann, Markus Loeffler, Michael Pfreundschuh

    Publicado 2019
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  17. 17
    Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?

    Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia? por Christoph Röllig, Michael Krämer, Christoph Schliemann, Jan‐Henrik Mikesch, Björn Steffen, Alwin Krämer, Richard Noppeney, Kerstin Schäfer‐Eckart, Stefan W. Krause, Mathias Hänel, Regina Herbst, Volker Kunzmann, Hermann Einsele, Edgar Jost, Tim H. Brümmendorf, Sebastian Scholl, Andreas Hochhaus, Andreas Neubauer, Kristina Sohlbach, Lars Fransecky, Martin Kaufmann, Dirk Niemann, Markus Schaich, Norbert Frickhofen, Alexander Kiani, Frank Heits, Ulrich Krümpelmann, Ulrich Kaiser, Johannes Kullmer, Maxi Wass, Friedrich Stölzel, Malte von Bonin, Jan Moritz Middeke, Christian Thiede, Johannes Schetelig, Wolfgang E. Berdel, Gerhard Ehninger, Claudia D. Baldus, Carsten Müller‐Tidow, Uwe Platzbecker, Hubert Serve, Martin Bornhäuser

    Publicado 2020
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  18. 18
    Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial

    Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial por Christoph Röllig, Hubert Serve, Richard Noppeney, Maher Hanoun, Utz Krug, Claudia D. Baldus, Christian Brandts, Volker Kunzmann, Hermann Einsele, Alwin Krämer, Carsten Müller‐Tidow, Kerstin Schäfer‐Eckart, Andreas Neubauer, Andreas Burchert, Aristoteles Giagounidis, Stefan W. Krause, Andréas Mackensen, Walter E. Aulitzky, Regina Herbst, Mathias Hänel, Norbert Frickhofen, Johannes Kullmer, Ulrich Kaiser, Alexander Kiani, Hartmut Link, Thomas Geer, Albrecht Reichle, Christian Junghanß, Roland Repp, Achim Meinhardt, Heinz Dürk, Ina‐Maria Klut, Martin Bornhäuser, Markus Schaich, Stefani Parmentier, Martin Görner, Christian Thiede, Malte von Bonin, Uwe Platzbecker, Johannes Schetelig, Michael Krämer, Wolfgang E. Berdel, Gerhard Ehninger

    Publicado 2021
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  19. 19
    Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial

    Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomi... por Christoph Röllig, Hubert Serve, Andreas Hüttmann, Richard Noppeney, Carsten Müller‐Tidow, Utz Krug, Claudia D. Baldus, Christian Brandts, Volker Kunzmann, Hermann Einsele, Alwin Krämer, Kerstin Schäfer‐Eckart, Andreas Neubauer, Andreas Burchert, Aristoteles Giagounidis, Stefan W. Krause, Andréas Mackensen, Walter E. Aulitzky, Regina Herbst, Mathias Hänel, Alexander Kiani, Norbert Frickhofen, Johannes Kullmer, Ulrich Kaiser, Hartmut Link, Thomas Geer, A. Reichle, Christian Junghanß, Roland Repp, Frank Heits, Heinz Dürk, Jana Hase, Ina‐Maria Klut, Thomas Illmer, Martin Bornhäuser, Markus Schaich, Stefani Parmentier, Martin Görner, Christian Thiede, Malte von Bonin, Johannes Schetelig, Michael Krämer, Wolfgang E. Berdel, Gerhard Ehninger

    Publicado 2015
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  20. 20
    MYC/MIZ1-dependent gene repression inversely coordinates the circadian clock with cell cycle and proliferation

    MYC/MIZ1-dependent gene repression inversely coordinates the circadian clock with cell cycle and proliferation por Anton Shostak, Bianca Ruppert, Nati Ha, Philipp Bruns, Umut H. Toprak, Chris Lawerenz, Peter Lichter, Bernhard Radlwimmer, Roland Eils, Benedikt Brors, Sylwester Radomski, Ingrid Scholz, Gesine Richter, R. Siebert, Susanne Wagner, Andrea Haake, Julia Richter, Sietse Aukema, Ole Ammerpohl, Christina Lopez, Inga Nagel, Inga Vater, Rabea Wagner, Christoph Borst, Siegfried Haas, Marius Rohde, Birgit Burkhardt, Jasmin Lisfeld, Alexander Claviez, Martin Dreyling, Sonja Eberth, Lorenz Trümper, Dieter Kube, Christina Stadler, Hermann Einsele, Norbert Frickhofen, Martin‐Leo Hansmann, Dennis Karsch, Michael Kneba, Luisa Mantovani‐Löffler, Peter Staib, Stephan Stilgenbauer, German Ott, Ralf Küppers, Marc A. Weniger, Michael Hummel, Dido Lenze, Monika Szczepanowski, Wolfram Klapper, Ulrike Kostezka, Peter M√oller, Andreas Rosenwald, Ellen Leich, Jordan Pischimariov, Vera Binder, Arndt Borkhardt, Kebria Hezaveh, Jessica I. Hoell, Philip Rosenstiel, Markus B. Schilhabel, Stefan Schreiber, Stephan Wolf, Gero Doose, Steve Hoffmann, Helene Kretzmer, David Langenberger, Hans Binder, Lydia Hopp, Markus Kreuz, Markus Loeffler, Maciej Rosolowski, Jan O. Korbel, Stéphanie Sungalee, Peter F. Stadler, Thorsten Zenz, Roland Eils, Matthias Schlesner, Axel Diernfellner, Michael Brunner

    Publicado 2016
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: